Verified Clinical Questions & Expert Doctor Answers
Q1
What is GLP-1 and how does it work for weight loss?
Direct Answer: GLP-1 (glucagon-like peptide-1) is a natural gut hormone your body releases after eating. It signals fullness to the brain, slows how fast the stomach empties, and helps regulate blood sugar — so you feel satisfied on less food.
GLP-1 medicines (Mounjaro, Ozempic, Wegovy) mimic this hormone at stronger, longer-lasting levels via a once-weekly injection. They are prescription-only and work best under doctor supervision combined with diet and activity changes.
Q2
How do GLP-1 drugs like Mounjaro and Ozempic work?
Direct Answer: They copy the GLP-1 hormone's effects at higher intensity: they suppress appetite through brain satiety signals, slow gastric emptying so you stay full longer, improve insulin release, and reduce glucagon (which lowers blood sugar). Mounjaro (tirzepatide) goes one step further by also activating GIP, a second metabolic pathway.
The effect builds gradually as the dose is escalated over weeks. Most people notice reduced hunger and smaller portions within the first month.
Q3
Who is eligible for GLP-1 weight loss treatment in India?
Direct Answer: Generally, adults with a BMI of 30 or above, or a BMI of 27+ with a weight-related condition such as type 2 diabetes, hypertension, sleep apnea, or PCOS. A registered doctor must assess you and write a prescription — these are not over-the-counter drugs.
They are not suitable for everyone: people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, a history of pancreatitis, or who are pregnant should avoid them. Your doctor will screen for these.
Q4
What is the difference between Mounjaro and Ozempic?
Direct Answer: Mounjaro contains tirzepatide, which targets two receptors (GLP-1 + GIP); Ozempic contains semaglutide, which targets GLP-1 only. In trials, Mounjaro delivered slightly greater average weight loss. In India, Mounjaro launched in March 2025 and is widely available, while Ozempic itself has not officially launched here yet.
Both are once-weekly injections with similar gastrointestinal side effects. Novo Nordisk's weight-loss version of semaglutide, Wegovy, launched in India in July 2025.
Q5
Is Mounjaro safe for long-term use?
Direct Answer: In clinical trials running 72 weeks and beyond, Mounjaro showed a manageable safety profile under medical supervision — most side effects are gastrointestinal and tend to fade. However, true multi-year data is still accumulating, and it carries serious (rare) risks including pancreatitis, gallbladder problems, and a boxed warning about thyroid tumors seen in rodents.
Long-term use requires ongoing doctor monitoring — periodic blood work, dose reviews, and a plan for nutrition and muscle preservation. It is not a drug to take casually or without follow-up.
Q6
What are the most common side effects of Mounjaro?
Direct Answer: Nausea, vomiting, diarrhea, constipation, indigestion, and reduced appetite — most common in the first few weeks and after each dose increase, then usually easing. Rare but serious effects include pancreatitis, gallbladder disease, kidney injury from dehydration, and allergic reactions.
Eating small, low-fat meals, stopping when full, and staying hydrated meaningfully reduce the common side effects. Seek medical help for severe or persistent abdominal pain, or vomiting that prevents fluid intake.
Q7
How much weight can you lose on Mounjaro in 6 months?
Direct Answer: In clinical trials, average weight loss reached roughly 15% of body weight at about a year and a half; at the 6-month mark, many patients see 10–15% depending on dose, diet, and activity. Individual results vary widely — some lose more, some less.
Indian medical weight-loss programs combining GLP-1 therapy with doctor guidance and coaching commonly report 15–20% over 6–12 months. Sustained habits matter more than speed.
Q8
Do you need a prescription for Mounjaro in India?
Direct Answer: Yes. Mounjaro is a prescription-only medicine in India — licensed pharmacies are legally required to see a valid prescription from a registered medical practitioner before dispensing it.
Be cautious of any seller offering it without a prescription; that is both illegal and a red flag for counterfeit product.
Q9
How much does Mounjaro cost per month in India?
Direct Answer: Roughly ₹13,000–17,500 per month at starting doses (2.5–5 mg), rising to about ₹25,000–27,500 per month at higher doses via the KwikPen. After the GST cut from 18% to 5% (effective 22 Sep 2026), the 5 mg vial's monthly cost dropped to approximately ₹16,404.
Prices vary by dose, format (vial vs KwikPen), and pharmacy — and they change frequently, so verify the current MRP. Factor in consultation and lab-test costs on top of the drug itself.
Q10
What happens if you stop taking Mounjaro?
Direct Answer: Appetite usually returns to previous levels, and clinical trials show most people regain a substantial portion of the lost weight within a year of stopping — unless they maintain the diet, activity, and behavioural changes built during treatment.
This is why doctor-led programs pair the medicine with habit coaching. If you plan to stop, do it with your doctor and a maintenance plan — not abruptly on your own.
Q11
Can you drink alcohol while on Mounjaro?
Direct Answer: Alcohol is not strictly prohibited, but doctors generally advise limiting it: it worsens nausea, adds empty calories that work against weight loss, can destabilise blood sugar, and heavy drinking raises the risk of pancreatitis.
If you do drink, keep it occasional and moderate, avoid it around dose-increase weeks when nausea peaks, and discuss your habits openly with your doctor.
Q12
What foods should you avoid on Mounjaro?
Direct Answer: Greasy and fried foods, very sugary foods and drinks, large heavy meals, carbonated beverages, and alcohol — all of these worsen nausea, bloating, and other GI side effects. Small, protein-rich, lower-fat meals are best tolerated.
In an Indian diet context: go easy on deep-fried snacks, rich oily curries in large portions, mithai, and sugary chai. Dal, paneer, eggs, curd, vegetables, and controlled portions of roti or rice are generally well tolerated.
Q13
Is generic semaglutide as effective as Ozempic?
Direct Answer: Approved generics contain the identical active ingredient (semaglutide) and must meet regulatory bioequivalence standards, so they are expected to work the same as the branded version. India's semaglutide patent expired in March 2026, and 40+ manufacturers have since launched versions starting around ₹1,290 per month.
Real-world effectiveness also depends on correct dosing, proper cold-chain storage, and medical supervision. Buy only from licensed pharmacies and be wary of suspiciously cheap or no-prescription sources.
Q14
Which is better for weight loss, Mounjaro or Wegovy?
Direct Answer: Head-to-head trial data favours tirzepatide (Mounjaro): it averaged around 20% weight loss versus roughly 14% for semaglutide (Wegovy) in the SURMOUNT-5 comparison. Pricing is comparable at maintenance doses — verify current MRPs before deciding on cost.
"Better" still depends on the individual — tolerability, cost, availability, and your medical history all matter. Your doctor should make the call, not a headline.
Q15
How does tirzepatide differ from semaglutide?
Direct Answer: Tirzepatide (the drug in Mounjaro) activates two hormone receptors — GLP-1 and GIP — while semaglutide (Ozempic, Wegovy) activates GLP-1 only. The dual action produces stronger appetite suppression and greater average weight loss in clinical trials.
Both are once-weekly injections with a similar side-effect profile (mainly gastrointestinal). Dosing schedules and maximum doses differ, so they are not interchangeable without a doctor's plan.
Q16
What BMI qualifies for GLP-1 treatment in India?
Direct Answer: Per the approved drug labels: a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related comorbidity such as type 2 diabetes, hypertension, abnormal cholesterol, or sleep apnea. Your doctor confirms eligibility after screening.
BMI = weight in kg ÷ (height in metres)². For reference, at 1.65 m tall, a BMI of 27 is about 73.5 kg and a BMI of 30 is about 81.7 kg.
Q17
Are GLP-1 drugs covered by insurance in India?
Direct Answer: Generally, no — most Indian health insurance policies exclude obesity and weight-loss treatment. Use prescribed specifically for diabetes may be covered under some policies, and CGHS issued GLP-1 guidelines in 2026, but weight-loss coverage remains the exception.
The coverage landscape is evolving as these drugs go mainstream, so check your specific policy wording — and expect most patients to pay out of pocket for now.
Q18
What is Ozempic face and how to prevent it?
Direct Answer: "Ozempic face" is the gaunt, hollowed facial appearance that can follow rapid fat loss — it is not unique to any one drug; any fast, large weight loss can cause it. The best prevention is losing weight gradually, eating enough protein, doing resistance training, and staying hydrated.
If facial fat loss concerns you, talk to your doctor about a slower dose-escalation pace. Dermatological options exist for after significant loss, but prevention during treatment works best.
Q19
How to manage nausea on Mounjaro?
Direct Answer: Eat small, bland, low-fat meals; stop eating as soon as you feel full; avoid strong food smells and greasy or spicy food; sip water through the day; ginger (tea or chews) helps many people. Nausea usually peaks for a few days after each dose increase and then fades.
If vomiting is persistent, you can't keep fluids down, or you feel dizzy — contact your doctor promptly, because dehydration on these medicines can injure the kidneys. Don't just "push through" severe symptoms.
Q20
Can Mounjaro be used for PCOS weight loss?
Direct Answer: Mounjaro is not specifically approved for PCOS, but some doctors in India prescribe GLP-1 medicines for weight management in PCOS patients, because losing weight improves insulin resistance — a core driver of PCOS symptoms. It must be doctor-supervised.
The medicine addresses the weight and metabolic side of PCOS, not the condition itself; it is usually part of a broader plan with your endocrinologist or gynaecologist covering hormones, cycles, and fertility goals.
Q21
What is the Mounjaro dose escalation schedule?
Direct Answer: The standard schedule is 2.5 mg once weekly for 4 weeks, then 5 mg weekly for at least 4 weeks, then increases of 2.5 mg every 4 or more weeks as tolerated — up to a maximum of 15 mg weekly. Your doctor sets the pace based on your response and side effects.
Never escalate faster on your own to "speed up" results — faster titration sharply increases nausea and vomiting risk without meaningfully improving outcomes.
Q22
Is it safe to buy Mounjaro online in India?
Direct Answer: It is safe only from licensed online pharmacies that require a valid prescription (such as Tata 1mg or PharmEasy with Rx upload). Avoid no-prescription sellers, social-media dealers, and listings priced far below market — counterfeit GLP-1 medicines are a documented risk, and the drug needs proper cold-chain handling.
Before ordering, verify the pharmacy's drug license, check that the pack is sealed with intact batch/expiry labelling, and confirm how they handle refrigerated delivery.
Q23
How should Mounjaro be stored?
Direct Answer: Refrigerate at 2–8°C and never freeze it. The KwikPen format can typically be kept at room temperature (below 30°C) for a limited number of days — check your pack's insert for the exact limit — and always protect it from light.
If you're unsure whether a pen was stored correctly (e.g., after a delivery delay), ask your pharmacist before using it rather than guessing.
Q24
What diet works best with GLP-1 medication?
Direct Answer: A higher-protein, fibre-rich, lower-fat diet with small, frequent meals. In Indian terms: dal, paneer, eggs, curd, soya, vegetables, and measured portions of roti or rice — while cutting back on fried snacks, sweets, and sugary drinks.
Protein plus resistance training 2–3 times a week is the key combination: it preserves muscle while the medicine drives fat loss, which is what keeps the weight off long-term.
Q25
Do GLP-1 drugs work without exercise?
Direct Answer: Yes — clinical trials show significant weight loss even with only modest activity, because appetite suppression does most of the work. But adding exercise, especially strength training 2–3 times a week, preserves muscle, improves the amount and quality of weight lost, and helps prevent regain.
Without protein intake and resistance work, roughly a quarter to a third of lost weight can be lean muscle rather than fat — so "no exercise" works, but "some exercise" works much better.